I think combination therapy is coming; it’s just a question of which combinations,’ says Arthur Kavanaugh, MD.

US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight ... have gained significant attention," says Dr. Ambrish Mithal, Chairman & Head - Endocrinology & Diabetes, Max ...

Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...

While Mounjaro gives Lilly a first-mover advantage in India ... Top generics makers such as Cipla, Dr Reddy’s, Lupin, Natco Pharma, Mankind Pharma, and Biocon are all gearing up to launch ...

Dr Reddy’s Laboratories is also working on a generic version of Wegovy. (Image/Getty) US pharma major Eli Lilly on Thursday launched its global bestseller anti-obesity and diabetes drug Mounjaro ...

providing healthcare providers with an innovative option to treat these diseases,” said Dr. Manish Mistry, Senior Medical Director, Lilly India. Tirzepatide, another injectable medication for ...

providing healthcare providers with an innovative option to treat these diseases,” said Dr. Manish Mistry, Senior Medical Director, Lilly India. Once-a-weekly, prescription-based medicine ...

Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Eli Lilly and Co. has begun selling its blockbuster ...

Lilly beats Novo Nordisk to launch weight-loss drug in India Mounjaro's 5 mg vial priced at around $50, 2.5 mg at about $40 Drug's pricing may limit accessibility in India, analyst says Novo's ...

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India after receiving regulatory approval. With rising obesity and diabetes rates, India presents a significant market opportunity ...